EUVIMEDOpdag EUVIMED
Crossref

Curcumin Analogs Containing Pyrazole–Pyridine Hybrids as Novel Anticancer Agents: Synthesis, Cytotoxicity, Apoptosis Induction, and Molecular Modeling

Nam Q H Doan iD, Huyen T T Nguyen, Hoang-Thuc Huynh iD, Tuyen Ngoc Truong iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500577 ↗

At a glance

Journal article in ChemMedChem, 2025. Written by Nam Q H Doan and 3 co-authors. Institution: School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 41 Dinh Tien Hoang Street, Sai Gon Ward, Ho Chi Minh City, 70000, Vietna…. Major MEDLINE topics: Pyridines, Antineoplastic Agents, Apoptosis, Pyrazoles. 60 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In recent years, curcumin analogs have not only demonstrated potent anticancer activities but have also addressed several limitations of curcumin itself, thereby remaining a promising focus of research within the scientific community. Building upon the findings of our previous studies, structural modifications of potent curcumin analogs fused with 1 H ‐pyrazole are performed by applying the bioisosteric replacement strategy of a benzene ring with a pyridine ring, to develop a series of novel curcumin analogs containing pyrazole–pyridine hybrids ( 3a –4h ) as promising anticancer agents. Among them, curcumin analog 4c emerges as the most potent compound, exhibiting the strongest cytotoxicity against various human cancer cell lines, including HepG2 (liver), MDA‐MB‐231 (breast), and A549 (lung), as well as significant apoptosis‐inducing effects in HepG2 cells. Furthermore, compound 4c is predicted to possess a favorable physicochemical–pharmacokinetic–toxicological profile, as well as an effective binding mode at the colchicine‐binding site of the α , β ‐tubulin heterodimer. Importantly, the bioisosteric replacement in compound 4c is found to exert beneficial effects on its anticancer activities, physicochemical–pharmacokinetic–toxicological properties, and binding affinity, in comparison with its parent compounds.

Subjects

MeSH terms (MEDLINE)

PyridinesAntineoplastic AgentsApoptosisPyrazolesCurcuminHumansDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationMolecular StructureModels, MolecularCell Line, TumorDose-Response Relationship, DrugTubulin

Author keywords

apoptosiscolchicine‐binding sitecurcumin analoguescytotoxicpyrazolepyridinetubulin

Substances

PyridinesAntineoplastic AgentsPyrazolesCurcuminpyrazolepyridineTubulin

Authors and institutions

  • School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 41 Dinh Tien Hoang Street, Sai Gon Ward, Ho Chi Minh City, 70000, Vietnam.

ORCID profiles: Nam Q H Doan, Hoang-Thuc Huynh, Tuyen Ngoc Truong

Cite

APA

Doan, N. Q. H., Nguyen, H. T. T., Huynh, H. T., & Truong, T. N. (2025). Curcumin Analogs Containing Pyrazole–Pyridine Hybrids as Novel Anticancer Agents: Synthesis, Cytotoxicity, Apoptosis Induction, and Molecular Modeling. ChemMedChem. https://doi.org/10.1002/cmdc.202500577

Vancouver

Doan NQH, Nguyen HTT, Huynh HT, Truong TN. Curcumin Analogs Containing Pyrazole–Pyridine Hybrids as Novel Anticancer Agents: Synthesis, Cytotoxicity, Apoptosis Induction, and Molecular Modeling. ChemMedChem. 2025. doi:10.1002/cmdc.202500577

BibTeX
@article{Doan2025,
  author = {Doan, Nam Q H and Nguyen, Huyen T T and Huynh, Hoang-Thuc and Truong, Tuyen Ngoc},
  title = {Curcumin Analogs Containing Pyrazole–Pyridine Hybrids as Novel Anticancer Agents: Synthesis, Cytotoxicity, Apoptosis Induction, and Molecular Modeling},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500577}
}
Start for free →